NCT00126087

Brief Summary

The investigators plan to improve the learning of motor skills by pharmacological means (dopamine), and by noninvasive brain stimulation. They will study both healthy subjects and chronic stroke patients. In addition, they want to study the mechanisms of enhanced learning, on the molecular and the systems level.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for phase_4 stroke

Timeline
Completed

Started Jul 2005

Longer than P75 for phase_4 stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 31, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 2, 2005

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2007

Completed
5.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
Last Updated

January 21, 2013

Status Verified

January 1, 2013

Enrollment Period

2.4 years

First QC Date

July 31, 2005

Last Update Submit

January 18, 2013

Conditions

Keywords

dopamineNMDA receptorbrain imagingneuroplasticitylearningtranscranial direct current stimulationrehabilitationaging

Outcome Measures

Primary Outcomes (1)

  • Procedural motor learning (decrease in reaction time in ms) after the respective intervention (dopamine, transcranial direct current stimulation), compared to placebo

Interventions

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy Volunteers:
  • Normal neurological examination
  • Mini Mental State Examination of \> 27
  • Right handedness
  • Stroke Patients:
  • Cortical or subcortical stroke with an initial severe hemiparesis Medical Research Council (MRC) scale \< 2 that has recovered to a degree that patients are able to perform the proposed task (in general \> MRC 4.5, with low spasticity, work in progress on motor learning in stroke patients)
  • At least 1 year post-stroke
  • Mini Mental State Examination of \> 27
  • Right-handedness

You may not qualify if:

  • Healthy Volunteers and Stroke Patients:
  • No antipsychotic, antidepressant drugs, and drugs affecting the dopaminergic system.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Münster, Department of Neurology

Münster, North Rhine-Westphalia, 48129, Germany

Location

Related Publications (2)

  • Floel A, Breitenstein C, Hummel F, Celnik P, Gingert C, Sawaki L, Knecht S, Cohen LG. Dopaminergic influences on formation of a motor memory. Ann Neurol. 2005 Jul;58(1):121-30. doi: 10.1002/ana.20536.

    PMID: 15984008BACKGROUND
  • Rosser N, Heuschmann P, Wersching H, Breitenstein C, Knecht S, Floel A. Levodopa improves procedural motor learning in chronic stroke patients. Arch Phys Med Rehabil. 2008 Sep;89(9):1633-41. doi: 10.1016/j.apmr.2008.02.030.

MeSH Terms

Conditions

Stroke

Interventions

Dopamine

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Biogenic MonoaminesBiogenic AminesAminesOrganic ChemicalsCatecholaminesCatecholsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbons

Study Officials

  • Agnes Flöel, MD

    University of Münster, Department of Neurology, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2005

First Posted

August 2, 2005

Study Start

July 1, 2005

Primary Completion

December 1, 2007

Study Completion

January 1, 2013

Last Updated

January 21, 2013

Record last verified: 2013-01

Locations